Results 131 to 140 of about 13,175 (219)

Adhesive hydrogel delivering ALA prevents the malignant transformation of oral leukoplakia. [PDF]

Mater Today Bio
Lin L, Ran J, Zhang Y, Guo S, Yin X, Tang C, Wang Y, Han W, Wang W, Song C.   +9 more
europepmc   +1 more source

Clinical and morphological features of oral leukoplakia

The review is devoted to modern perspectivesof the etiology, pathogenesis, diagnosis and prognostic factors of oral leukoplakia. The review describes modern non-invasive methods for detecting neoplasia in leukoplakia, such as optical coherence tomogra ...
Rodionov V.E., Babichenko I.I., Ivina A.A.   +2 more
core   +1 more source

Immune suppression, HLA-risk and potential future immune based targets of oral leukoplakia progression. [PDF]

Front Dent Med
Soni M, DeSantis B, Villa A, Kamoun M, Gates J.   +4 more
europepmc   +1 more source

Oral leukoplakia: still an enigmatic disorder. [PDF]

Med Oral Patol Oral Cir Bucal
Aguirre-Urizar JM.
europepmc   +1 more source

Histological Morphometry of the Oral Mucosa in Patients with Leukoplakia with Epithelial Dysplasia

Revista Finlay
Foundation: oral leukoplakia is one of the most common potentially malignant disorders worldwide. The study of the histopathological changes in oral leukoplakia is supported by the use of microscopic morphometry.
Yamilka Mesa González, Galia Ivis Pérez Rumbaut, Laura Naranjo Hernández, Grey Alicia Crespo Lechuga, Zuria Ayala Reina, Yisel Alonso Vila Yisel Alonso Vila   +5 more
doaj  

Descriptive transcriptomic profiling differentiates oral leukoplakia from proliferative verrucous leukoplakia and reveals distinct molecular signatures. [PDF]

Med Oral Patol Oral Cir Bucal
Pérez-Sayáns M, Vieira-E-Silva FF, Fernández-Rozadilla C, Carracedo Á, Carlés-González S, Lorenzo-Pouso AI, Pérez-Jardón A, Gándara-Vila P, García-García A, Suárez-Peñaranda JM, Blanco-Carrión A, Chamorro-Petronacci CM.   +11 more
europepmc   +1 more source

Yeast organisms associated with human oral leukoplakia

, 1986
Oral leukoplakia is a lesion of variable clinical behaviour and a malignant transformation rate of 3-6%. Leukoplakia exhibits various histologic features, hyperkeratinization being the most consistent.
Holmstrup, P., Vedtofte, P., Krogh, P., Pindborg, J. J.   +3 more
core  

Cancer Hallmarks Expression in Oral Leukoplakia: Systematic Review and Meta-Analysis. [PDF]

Oral Dis
González-Ruiz I, Ramos-García P, Boujemaoui-Boulaghmoudi H, Mjouel-Boutaleb N, González-Moles MA.   +4 more
europepmc   +1 more source

Azoxystrobin induces mitochondrial dysfunction and mitochondrial pathway apoptosis by targeting the Prx1 Trp87 and Thr90 sites in oral leukoplakia. [PDF]

Front Pharmacol
Li W, Shen Y, Li L, Wang M, Zhang M, Tang X.   +5 more
europepmc   +1 more source

Assessment of Promoter Hypermethylation in Tumor Suppressor Genes in Oral Leukoplakia and Oral Submucous Fibrosis. [PDF]

J Pharm Bioallied Sci
Abdul NS, Mhaske S, Afroz S, Nigam S, Jyoti B, Singaraju S, Shivakumar S, Channaiah SG.   +7 more
europepmc   +1 more source